An integrated approach to determining the risk of developing preeclampsia in pregnant women with hypertensive conditions
Abstract
Aim. Hypertensive disorders complicate one in ten pregnancies, which necessitates the development of new standards for determining the risk of preeclampsia and heart failure in pregnant women. To determine early clinical markers in pregnant women with gestational arterial hypertension (GAH) as sensitive diagnostic criteria for the development of hypertensive complications.
Materials and methods. The study included 91 pregnant women of the 2nd-3rd trimesters, divided into groups: healthy pregnant women (n=44) and with GAH (n=47) according to the ESC Guidelines 2018. Physical examination, blood pressure measurement, BMI calculation, detailed blood tests including lipidogram, coagulogram, determination of prolactin and NT-proBNP, echocardiography, vascular stress test to assess endothelial function were performed.
Results. Pregnant women with GAH were found to have morphofunctional changes in the heart, early signs of endothelial dysfunction, lipid and carbohydrate metabolism disorders. Microalbuminuria demonstrated high diagnostic value for detecting early renal dysfunction. The prognostic significance of prolactin and NT-proBNP levels was established.
Conclusion. Comprehensive early monitoring of clinical and biochemical parameters of pregnant women with GAG is necessary for timely detection of preeclampsia predictors. The results contribute to the improvement of diagnostic and preventive standards for the management of this cohort of patients.
About the Authors
List of references
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstro¨m-Lundqvist C, C´ıfkova´ R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018 Sep;39(34):3165–3241. https://doi.org/10.1093/eurheartj/ehy340.
World Health Organization. WHO recommendations on drug treatment for non-severe hypertension in pregnancy. 1st ed. Geneva: World Health Organization; 2020.
Stryuk RI. Puti resheniya problemy arterial’noy gipertonii pri beremennosti. Ross Kardiol Zh. 2013;(4):64–69 [Internet]. Available from: https://scardio.ru/content/education/articles/Struck_rkj_4_13.pdf. In Russian: Стрюк Р. И., «ПУТИ РЕШЕНИЯ ПРОБЛЕМЫ АРТЕРИАЛЬНОЙ ГИПЕРТОНИИ ПРИ БЕРЕМЕННОСТИ», Российский кардиологический журнал 2013, 4 (102): 64-69. [Онлайн]. Доступно на: https://scardio.ru/content/education/articles/Struck_rkj_4_13.pdf.
Say L, Chou D, Gemmill A, Tunc¸alp O¨ , Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014 Jun;2(6):e323–e333. https://doi.org/10.1016/S2214- 109X(14)70227-X.
Bokuda K, Ichihara A. Preeclampsia up to date—What’s going on? Hypertens Res. 2023 Aug;46(8):1900–1907. https://doi.org/10.1038/s41440-023-01323-w.
United Nations Population Fund. Trends in maternal mortality: 1990 to 2015 [Internet]. [cited 2025 Jan 22]. Available from: https://www.unfpa.org/publications/trends-maternal-mortality-1990-2015.
Babajanova ShD, et al. Tretiy otchet po konfidentsial’nomu issledovaniyu sluchaev materinskoy smertnosti (za 2016–2017 gg) [Internet]. Available from: https://perinatal-center.uz/medias/media/other/203/cemd- 3d-national-report-2016-2017.pdf. In Russian: Бабажанова Ш.Д, и другие, «Третий отчет по конфиден- циальному исследованию случаев материнской смертности (за 2016-2017гг)». [Онлайн]. Доступно на: https://perinatal-center.uz/medias/media/other/203/cemd-3d-national-report-2016-2017.pdf.
Myatt L, Roberts JM. Preeclampsia: syndrome or disease? Curr Hypertens Rep. 2015 Nov;17(11):83. https://doi.org/10.1007/s11906-015-0595-4.
McEvoy JW, Schmieder RE, Azizi M, Burnier M, De Buyzere M, Fazel S, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: Developed by the Task Force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). Eur Heart J. 2024 Oct;45(38):3912–4018. https://doi.org/10.1093/eurheartj/ehae178.
Role of arterial impairment in preeclampsia: should the paradigm shift? [Internet]. [cited 2025 Jan 23]. Available from: https://journals.physiology.org/doi/epdf/10.1152/ajpheart.01005.2020.
Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension. 2005 Dec;46(6):1243–1249. https://doi.org/10.1161/01.HYP.0000188408.49896.c5.
Pereira MM, Torrado J, Sosa C, Zo´calo Y, Bia D. Shedding light on the pathophysiology of preeclampsia- syndrome in the era of cardio-obstetrics: role of inflammation and endothelial dysfunction. Curr Hypertens Rev. 2022;18(1):17–33. https://doi.org/10.2174/1573402117666210218105951.
Kristensen JH, Basit S, Wohlfahrt J, Damholt MB, Boyd HA. Pre-eclampsia and risk of later kidney disease: nationwide cohort study. BMJ. 2019 Apr;365:l1516. https://doi.org/10.1136/bmj.l1516.
Ackerman CM, Platner MH, Spatz ES, Illuzzi JL, Xu X, Campbell KH, et al. Severe cardiovascular morbidity in women with hypertensive diseases during delivery hospitalization. Am J Obstet Gynecol. 2019;220(6):582.e1–582.e11.
Copyright (c) 2025 M. Садуллоева, Ф.А. Закирова , М.У. Турсунова , А.А. Абдухакимов , С.А. Икрамова , В.Х. Джураева (Автор)
This work is licensed under a Creative Commons Attribution 4.0 International License.